Terkko Navigator / -/ Feeds / " ( ( Vasta-aineiden sitoutumispaikat )|( Vasta-aineiden sitoutumiskohdat )|( Vasta-aineen "

Nanomaterials, Vol. 12, Pages 2248: PLGA Nanoparticles Grafted with Hyaluronic Acid to Improve Site-Specificity and Drug Dose Delivery in Osteoarthritis Nanotherapy

IJMS, Vol. 23, Pages 7193: Molecular Recognition of Surface Trans-Sialidases in Extracellular Vesicles of the Parasite Trypanosoma cruzi Using Atomic Force Microscopy (AFM)

Immune Escape Mechanisms of SARS-CoV-2 Delta and Omicron Variants against Two Monoclonal Antibodies That Received Emergency Use Authorization

SARS-CoV-2 antibody prevalence among homeless people and shelter workers in Denmark: a nationwide cross-sectional study

Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development

Integrating Conformational Dynamics and Perturbation-Based Network Modeling for Mutational Profiling of Binding and Allostery in the SARS-CoV-2 Spike Variant Complexes with Antibodies: Balancing Local and Global Determinants of Mutational Escape Mech

Viruses, Vol. 14, Pages 1326: ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-CoV-2 Spike Protein

Viruses, Vol. 14, Pages 1326: ORFeome Phage Display Reveals a Major Immunogenic Epitope on the S2 Subdomain of SARS-CoV-2 Spike Protein

Biosensors, Vol. 12, Pages 437: Ultrasensitive Detection of COVID-19 Virus N Protein Based on p-Toluenesulfonyl Modified Fluorescent Microspheres Immunoassay

Binding of complement factor h to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.

Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin.

Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development.

Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development.

High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post HIV Env trimer vaccination.

Binding of complement factor H to endothelial cells is mediated by the carboxy-terminal glycosaminoglycan binding site.

Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies.

Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS.

Antibodies Isolated from Rheumatoid Arthritis Patients against Lysine-Containing Proteus mirabilis O3 (S1959) Lipopolysaccharide May React with Collagen Type I.

A large scale analysis of genetic variants within putative miRNA binding sites in prostate cancer.

Site-Specific Modification of Single-Chain Affinity Ligands for Fluorescence Labeling, Radiolabeling, and Bioconjugation

Antibodies induced by ancestral SARS-CoV-2 strain that cross-neutralize variants from Alpha to Omicron BA.1

Antibodies to decorin-binding protein B (DbpB) in the diagnosis of Lyme neuroborreliosis in children.

Antibody development against medically important target proteins

Antibody Format and Serum Disposition Govern Ocular Pharmacokinetics of Intravenously Administered Protein Therapeutics

Antibodies, Vol. 11, Pages 6: Engineering an Enhanced EGFR Engager: Humanization of Cetuximab for Improved Developability

Binding of Duck Tembusu Virus Nonstructural Protein 2A to Duck STING Disrupts Induction of Its Signal Transduction Cascade To Inhibit Beta Interferon Induction.

Binding affinity landscapes constrain the evolution of broadly neutralizing anti-influenza antibodies

Binding affinity landscapes constrain the evolution of broadly neutralizing anti-influenza antibodies

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression

Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progression